|
시장보고서
상품코드
1516277
세계의 육종 치료제 시장(2024-2028년)Global sarcoma therapeutics market 2024-2028 |
||||||
육종 치료제 시장은 2023-2028년간 11억 1,080만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR) 8.51%로 성장할 전망입니다.
육종 치료제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.
현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 환자 지원 프로그램, 전략적 제휴 증가, 신약 발매 등이 시장 성장을 촉진하고 있습니다.
| 시장 범위 | |
|---|---|
| 기준년 | 2024년 |
| 종료년 | 2028년 |
| 예측 기간 | 2024-2028년 |
| 성장 모멘텀 | 가속 |
| YOY 2024 | 7.67% |
| CAGR | 8.51% |
| 증분액 | 11억 1,080만 달러 |
본 조사에서는 향후 몇 년간 육종 치료제 시장 성장을 가속하는 주요인 중 하나로서 질병 치료를 위한 신약 연구개발을 들고 있습니다. 또한 재정 지원 프로그램이나 상환 스킴, 재생의료의 출현은 시장의 큰 수요로 연결될 것입니다.
목차
제1장 주요 요약
- 시장 개요
제2장 시장 구도
- 시장 생태계
- 시장 특징
- 밸류체인 분석
제3장 시장 규모 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2023년)
- 시장 전망(2023-2028년)
제4장 시장 규모 실적
- 세계의 육종 치료제 시장(2018-2022년)
- 유형별 부문 분석(2018-2022년)
- 지역별 부문 분석(2018-2022년)
- 국가별 부문 분석(2018-2022년)
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제6장 시장 세분화 : 유형별
- 시장 세분화
- 비교 : 유형별
- 악성 연부 종양 : 시장 규모와 예측(2023-2028년)
- 골육종 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 유형별
제7장 고객 상황
- 고객 상황 개요
제8장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2023-2028년)
- 유럽 : 시장 규모와 예측(2023-2028년)
- 아시아 : 시장 규모와 예측(2023-2028년)
- 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
- 미국 : 시장 규모와 예측(2023-2028년)
- 중국 : 시장 규모와 예측(2023-2028년)
- 독일 : 시장 규모와 예측(2023-2028년)
- 캐나다 : 시장 규모와 예측(2023-2028년)
- 영국 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 지역별
제9장 성장 촉진요인, 과제, 기회 및 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회 및 성장 억제요인
제10장 경쟁 구도
- 개요
- 경쟁 구도
- 혼란 상황
- 업계 리스크
제11장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Agios Inc.
- Athenex Inc.
- Bayer AG
- Eisai Co. Ltd.
- GlaxoSmithKline Plc
- Ipsen Pharma
- Johnson and Johnson Services Inc.
- Karyopharm Therapeutics Inc.
- Novartis AG
- PharmaMar SA
제12장 부록
LSH 24.07.31The sarcoma therapeutics market is forecasted to grow by USD 1110.8 mn during 2023-2028, accelerating at a CAGR of 8.51% during the forecast period. The report on the sarcoma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patient assistance programs, increasing strategic alliances, and launch of novel drugs.
Technavio's sarcoma therapeutics market is segmented as below:
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 7.67% |
| CAGR | 8.51% |
| Incremental Value | $1110.8mn |
By Type
- Soft tissue sarcoma
- Osteosarcoma
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the r and d of new drugs for oh treatment as one of the prime reasons driving the sarcoma therapeutics market growth during the next few years. Also, financial assistance programs and reimbursements schemes and advent of regenerative medicine will lead to sizable demand in the market.
The report on the sarcoma therapeutics market covers the following areas:
- Sarcoma therapeutics market sizing
- Sarcoma therapeutics market forecast
- Sarcoma therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sarcoma therapeutics market vendors that include Adaptimmune Therapeutics plc, Advenchen Laboratories LLC, Agenus Inc., Agios Inc., Athenex Inc., Bayer AG, Bristol Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Ipsen Pharma, Johnson and Johnson Services Inc., Karyopharm Therapeutics Inc., LadRx Corp., Mirati Therapeutics Inc., Novartis AG, Pfizer Inc., PharmaMar SA, and SillaJen Co. Ltd.. Also, the sarcoma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Sarcoma Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Sarcoma Therapeutics Market 2018 - 2022 ($ million)
- 4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
- 6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 6.3 Soft tissue sarcoma - Market size and forecast 2023-2028
- Chart on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
- Chart on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
- Data Table on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
- 6.4 Osteosarcoma - Market size and forecast 2023-2028
- Chart on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
- Chart on Osteosarcoma - Year-over-year growth 2023-2028 (%)
- Data Table on Osteosarcoma - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
- 7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
- 8.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 8.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 8.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 8.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 8.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 8.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
- 9.1 Market drivers
- 9.2 Market challenges
- 9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 9.4 Market opportunities/restraints
10 Competitive Landscape
- 10.1 Overview
- 10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 10.3 Landscape disruption
- Overview on factors of disruption
- 10.4 Industry risks
- Impact of key risks on business
11 Competitive Analysis
- 11.1 Companies profiled
- Companies covered
- 11.2 Market positioning of companies
- Matrix on companies position and classification
- 11.3 Agios Inc.
- Agios Inc. - Overview
- Agios Inc. - Product / Service
- Agios Inc. - Key offerings
- 11.4 Athenex Inc.
- Athenex Inc. - Overview
- Athenex Inc. - Product / Service
- Athenex Inc. - Key offerings
- 11.5 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- 11.6 Eisai Co. Ltd.
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Segment focus
- 11.7 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- 11.8 Ipsen Pharma
- Ipsen Pharma - Overview
- Ipsen Pharma - Business segments
- Ipsen Pharma - Key offerings
- Ipsen Pharma - Segment focus
- 11.9 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- 11.10 Karyopharm Therapeutics Inc.
- Karyopharm Therapeutics Inc. - Overview
- Karyopharm Therapeutics Inc. - Product / Service
- Karyopharm Therapeutics Inc. - Key offerings
- 11.11 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 11.12 PharmaMar SA
- PharmaMar SA - Overview
- PharmaMar SA - Business segments
- PharmaMar SA - Key offerings
- PharmaMar SA - Segment focus
12 Appendix
- 12.1 Scope of the report
- 12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 12.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 12.4 Research methodology
- Research methodology
- 12.5 Data procurement
- Information sources
- 12.6 Data validation
- Data validation
- 12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 12.8 Data synthesis
- Data synthesis
- 12.9 360 degree market analysis
- 360 degree market analysis
- 12.10 List of abbreviations
- List of abbreviations
